Contract Services Clinical Research
Pixelgen Expands Asia Pacific Footprint With South Korea Distribution Agreement
- Pixelgen Technologies, Inc. and MDxK (Molecular Diagnostics Korea) Inc., part of DKSH Business Unit Technology, a leader in market expansion se...
December 16, 2025 | News
APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
APAC Biopharma in Review: What Truly Moved the Needle This Year Asia-Pacific (APAC) has cemented its status as a pivotal biopharmaceutical hub in 2025, ma...
December 15, 2025 | Report
Innovent Doses First Participant in Phase One Trial of Novel IL One RAP Antibody for Gout
Innovent Biologics, Inc. , a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment ...
December 11, 2025 | News
Cytiva And Fida Biosystems Partner To Strengthen Protein Interaction Analysis
Cytiva, a Danaher company and leader in the life sciences industry, and Fida Biosystems, a Danish company specializing in molecular analysis, have joined...
December 10, 2025 | News
SoluPet Partners With CHC To Launch Canine Cognitive Health Solution In Taiwan
SoluPet, the data and science-driven pet cognitive health company developing advanced cognitive-aging support for senior dogs, today announc...
December 10, 2025 | News
Bora Pharmaceuticals Forms Strategic Alliance with Corealis Pharma to Streamline Drug Development
Partnership creates simplified pathway from early development to commercial launch Bora Pharmaceuticals Co., Ltd. ("Bora", TWSE: 6472), a global leader ...
December 10, 2025 | News
Mango Sciences Partners with ImmunoACT to Expand Access to NexCAR19 CAR-T Therapy in India
Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI company, announced a strategic partnership with ImmunoAdoptive Cell Therapy (Immu...
December 08, 2025 | News
Replicate Bioscience Partners With Instituto Butantan To Advance Next Generation srRNA Rabies Vaccine Across Latin America
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunol...
December 05, 2025 | News
Neurimmune And Alexion Expand Global Collaboration To Advance NI009 For Light Chain Amyloidosis
Neurimmune announced that it has expanded on its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, AstraZeneca Rare Disease ...
December 05, 2025 | News
Kelun Biotech And Crescent Biopharma Forge Global Partnership To Advance Next Generation Oncology Therapies
Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets an...
December 05, 2025 | News
Antengene Secures Expanded Approvals For Xpovio In Hong Kong Across Multiple Myeloma And DLBCL
- XPOVIO® (selinexor) has received approvals for three indications in Hong Kong. These include its previous approval as the treatment for mul...
December 04, 2025 | News
Aurigene Oncology Reports Strong Early Phase One Results For AUR112 In Relapsed And Refractory Lymphomas
Aurigene Oncology Limited, a clinical-stage biopharmaceutical company developing novel therapies in oncology, announced initial clinical results...
December 04, 2025 | News
AdvanCell Launches Theraphase Two Expansion To Optimise Dosing For ADVC001 Across Key Prostate Cancer Settings
Clinical development of 212Pb-ADVC001 (ADVC001) is advancing rapidly with encouraging Phase 1b data presented at ESMO 2025 The Phase 2 expansion will ...
December 04, 2025 | News
Antengene Secures NMPA Approval for IND of CLINCH Two Combination Study in Gastric Cancer
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, develop...
December 03, 2025 | News
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
